Navigating the ethical clash between access to health information and proprietary databases

May 15, 2017, Baylor College of Medicine
Credit: CC0 Public Domain

Sharing medical information, including genomic data, has the potential to benefit public health. However, companies that generate that information have a legal right to protect it as a trade secret. Legal and ethical conflict exists between individuals' right to access their personal health information and the protection of these trade secrets, as examined in Science by a group of ethicists from Baylor College of Medicine's Center for Medical Ethics and Health Policy.

As a case study, Christi Guerrini, Dr. Amy McGuire and Dr. Mary Majumder look at the complaint filed against Myriad Genetics, the once-exclusive provider of genetic tests to screen for the BRCA1/2 breast cancer genes, by four of its clients who received genetic testing.

"This case presents a fascinating clash between two important rights: the right of individuals to access their information as it relates to their wellbeing and the right of innovators to protect their , which Myriad exercises in this case," said Guerrini, assistant professor in the Center. "Myriad has a legitimate commercial interest in protecting its algorithms and the huge amounts of data it amassed from BRCA1/2 testing, but its clients and the healthcare community have compelling personal and interests in accessing the information gathered from the tests."

The data gathered from these genetic tests can provide important insights when making an individual diagnosis or pursuing clinical treatments, thereby having a direct impact on patient care. On the other hand, if companies and innovators are able to keep certain pieces of data and their processes secret, they are more easily able to recover their investment in the project and use it to finance new diagnostic tests.

"As genetic testing continues to become more prevalent, we are going to see increasing challenges between the public and the companies doing the testing. Trying to mask protected health data, or information that can be individually identified to one person's health condition, under patents or trade secrets will result in more and more public backlash as the government figures out how to regulate genomic databases and client access," said McGuire, director of the Center.

But if clients were to exercise their data access rights and take back their genetic data, the question becomes how to interpret the data and amass it into a database that would be of value to others.

"This would be a legal win for the clients – for patients," said Majumder, associate professor in the Center. "However, these data are not user friendly, and the further step of assembling the data from lots of individuals into a database that rivals Myriad's will be a big logistical challenge."

In the end, the team at the Center envisions a partial win for both sides. A compromise will need to be reached between the data access right in HIPAA requiring these companies to disclose parts, or all, of the requested information to clients, and the legal right of companies like Myriad to protect that as a trade secret in order to stimulate competition and innovation.

Explore further: Genomic data sharing is critical to improving genetic health care

More information: Christi J. Guerrini et al. Myriad take two: Can genomic databases remain secret?, Science (2017). DOI: 10.1126/science.aal3224

Related Stories

Genomic data sharing is critical to improving genetic health care

January 5, 2017
There are an estimated 5,000 - 7,000 rare genetic diseases, each of which can vary dramatically and be caused by a multitude of different genetic changes. Even common diseases with genetic influences may also have rare variants ...

Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine

October 31, 2012
In response to the on-line publication by the European Journal of Human Genetics today (Wednesday) of an article by US researchers led by Dr. Robert Cook-Degan, a former member of the US Office of Technology Assessment, showing ...

The expanding influence of genomics on society

May 4, 2017
From prenatal genetic screening to the genetic testing of women with family histories of breast cancer, genomics is rapidly becoming a fixture in our lives. The National Human Genome Research Institute (NHGRI) has, since ...

Direct-to-consumer genomics: Harmful or empowering?

February 23, 2017
Thanks to recent scientific advances and plunging costs in genetic sequencing, consumers now can order simple, inexpensive, mail-in genetic tests to learn more about health risks, inherited traits and ancestry. But, is it ...

Making the case for global genomic data sharing

November 8, 2016
The scientific community may be overlooking a significant barrier to international collaboration reflected in a series of recent surveys: potential public resistance to sharing of genomic and other health data across national ...

Customers who receive genetic health data not alarmed by results, find information useful

January 11, 2017
As consumers have been able to learn more about their genetic makeup in recent years through personal genomic testing, one big criticism has been that without someone to interpret it, the health information could be harmful ...

Recommended for you

New Tourette disorder genes come to light

September 25, 2018
In the largest DNA sequencing study of Tourette Disorder (TD) to date, UC San Francisco researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development ...

Genetic testing: Not a one-and-done deal

September 25, 2018
Genetic testing can play a substantial role in medical management by uncovering changes in genes that are associated with an increased risk for hereditary cancers. A new research study from investigators at UT Southwestern ...

Genetic determinants of telomere length in African American youth

September 25, 2018
Telomeres are DNA-protein structures that play a vital role in maintaining DNA stability and integrity. Telomere length (TL) is an important biomarker of aging and overall health, but TL has been mostly studied in adult populations ...

Thousands of unknown DNA changes in the developing brain revealed by machine learning

September 24, 2018
Unlike most cells in the rest of our body, the DNA (the genome) in each of our brain cells is not the same: it varies from cell to cell, caused by somatic changes. This could explain many mysteries—from the cause of Alzheimer's ...

Mitochondrial diseases could be treated with gene therapy, study suggests

September 24, 2018
Researchers have developed a genome editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

Height may be risk factor for varicose veins, study finds

September 24, 2018
The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.